APO Research
Talk to an analyst

APO RESEARCH · REPORT

Custom Antibody Development and Production Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Custom Antibody Development and Production Service Market Outlook and Growth Opportunities 2026

5 June 2026210 pages

Choose your research edition.

Industry ResearchCustom Antibody Development and Production Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Antibody Development and Production Service Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Custom Antibody Development and Production Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Antibody Development and Production Service Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Antibody Development and Production Service Market Analysis and Forecast 2026-2032222 pages · $4,950 USD

Market perspective

The global Custom Antibody Development and Production Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Custom Antibody Development and Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Custom Antibody Development and Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom Antibody Development and Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Custom Antibody Development and Production Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Custom Antibody Development and Production Service market include Thermo Fisher Scientific, Sino Biological, Inotiv, GenScript, R&D Systems, Proteogenix, BBI Solutions, Bio-Rad Laboratories and Bio-Techne, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Custom Antibody Development and Production Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Custom Antibody Development and Production Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Custom Antibody Development and Production Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Antibody Development and Production Service market.

Custom Antibody Development and Production Service Segment by Company

Thermo Fisher Scientific

Sino Biological

Inotiv

GenScript

R&D Systems

Proteogenix

BBI Solutions

Bio-Rad Laboratories

Bio-Techne

Abcam

OriGene

Innovagen

AltaBioscience

Creative Biolabs

Rockland

Biosynth

ProSci

Abclonal

Eurogentec

Creative Diagnostics

BioGenes

Biomolecular Discovery Services, LLC.

Proteintech Group

HUABIO

MyBioSource

Custom Antibody Development and Production Service Segment by Type

Polyclonal Antibody

Monoclonal Antibody

Recombinant Antibody

Custom Antibody Development and Production Service Segment by Application

Research

Diagnosis

Treatment and Clinical Practice

Custom Antibody Development and Production Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Custom Antibody Development and Production Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Custom Antibody Development and Production Service key companies, revenue, market share, and recent developments.

3. To split the Custom Antibody Development and Production Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Custom Antibody Development and Production Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Custom Antibody Development and Production Service significant trends, drivers, influence factors in global and regions.

6. To analyze Custom Antibody Development and Production Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Antibody Development and Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Antibody Development and Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Antibody Development and Production Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Antibody Development and Production Service industry.

Chapter 3: Detailed analysis of Custom Antibody Development and Production Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Custom Antibody Development and Production Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Custom Antibody Development and Production Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Custom Antibody Development and Production Service Industry Trends Table 2. Custom Antibody Development and Production Service Industry Drivers Table 3. Custom Antibody Development and Production Service Industry Opportunities and Challenges Table 4. Custom Antibody Development and Production Service Industry Restraints Table 5. Global Custom Antibody Development and Production Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Custom Antibody Development and Production Service Revenue Share by Company (2021-2026) Table 7. Global Custom Antibody Development and Production Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Custom Antibody Development and Production Service Key Company Manufacturing Base & Headquarters Table 9. Global Custom Antibody Development and Production Service Company, Product Type & Application Table 10. Global Custom Antibody Development and Production Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Custom Antibody Development and Production Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Polyclonal Antibody Table 15. Significant Companies of Monoclonal Antibody Table 16. Significant Companies of Recombinant Antibody Table 17. Global Custom Antibody Development and Production Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Custom Antibody Development and Production Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Custom Antibody Development and Production Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Custom Antibody Development and Production Service Sales Value Share by Type (2021-2026) Table 21. Global Custom Antibody Development and Production Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Research Table 23. Significant Companies of Diagnosis Table 24. Significant Companies of Treatment and Clinical Practice Table 25. Global Custom Antibody Development and Production Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Custom Antibody Development and Production Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Custom Antibody Development and Production Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Custom Antibody Development and Production Service Sales Value Share by Application (2021-2026) Table 29. Global Custom Antibody Development and Production Service Sales Value Share by Application (2027-2032) Table 30. Global Custom Antibody Development and Production Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Custom Antibody Development and Production Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Custom Antibody Development and Production Service Sales Value Share by Region (2021-2026) Table 33. Global Custom Antibody Development and Production Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Custom Antibody Development and Production Service Sales Value Share by Region (2027-2032) Table 35. Global Custom Antibody Development and Production Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Custom Antibody Development and Production Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Custom Antibody Development and Production Service Sales Value Market Share by Country (2021-2026) Table 38. Global Custom Antibody Development and Production Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Custom Antibody Development and Production Service Sales Value Market Share by Country (2027-2032) Table 40. Thermo Fisher Scientific Company Information Table 41. Thermo Fisher Scientific Business Overview Table 42. Thermo Fisher Scientific Custom Antibody Development and Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Thermo Fisher Scientific Custom Antibody Development and Production Service Product Portfolio Table 44. Thermo Fisher Scientific Recent Development Table 45. Sino Biological Company Information Table 46. Sino Biological Business Overview Table 47. Sino Biological Custom Antibody Development and Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Sino Biological Custom Antibody Development and Production Service Product Portfolio Table 49. Sino Biological Recent Development Table 50. Inotiv Company Information Table 51. Inotiv Business Overview Table 52. Inotiv Custom Antibody Development and Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Inotiv Custom Antibody Development and Production Service Product Portfolio Table 54. Inotiv Recent Development Table 55. GenScript Company Information Table 56. GenScript Business Overview Table 57. GenScript Custom Antibody Development and Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. GenScript Custom Antibody Development and Production Service Product Portfolio Table 59. GenScript Recent Development Table 60. R&D Systems Company Information Table 61. R&D Systems Business Overview Table 62. R&D Systems Custom Antibody Development and Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. R&D Systems Custom Antibody Development and Production Service Product Portfolio Table 64. R&D Systems Recent Development Table 65. Proteogenix Company Information Table 66. Proteogenix Business Overview Table 67. Proteogenix Custom Antibody Development and Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Proteogenix Custom Antibody Development and Production Service Product Portfolio Table 69. Proteogenix Recent Development Table 70. BBI Solutions Company Information Table 71. BBI Solutions Business Overview Table 72. BBI Solutions Custom Antibody Development and Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. BBI Solutions Custom Antibody Development and Production Service Product Portfolio Table 74. BBI Solutions Recent Development Table 75. Bio-Rad Laboratories Company Information Table 76. Bio-Rad Laboratories Business Overview Table 77. Bio-Rad Laboratories Custom Antibody Development and Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Bio-Rad Laboratories Custom Antibody Development and Production Service Product Portfolio Table 79. Bio-Rad Laboratories Recent Development Table 80. Bio-Techne Company Information Table 81. Bio-Techne Business Overview Table 82. Bio-Techne Custom Antibody Development and Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Bio-Techne Custom Antibody Development and Production Service Product Portfolio Table 84. Bio-Techne Recent Development Table 85. Abcam Company Information Table 86. Abcam Business Overview Table 87. Abcam Custom Antibody Development and Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Abcam Custom Antibody Development and Production Service Product Portfolio Table 89. Abcam Recent Development Table 90. OriGene Company Information Table 91. OriGene Business Overview Table 92. OriGene Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. OriGene Custom Antibody Development and Production Service Product Portfolio Table 94. OriGene Recent Development Table 95. Innovagen Company Information Table 96. Innovagen Business Overview Table 97. Innovagen Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Innovagen Custom Antibody Development and Production Service Product Portfolio Table 99. Innovagen Recent Development Table 100. AltaBioscience Company Information Table 101. AltaBioscience Business Overview Table 102. AltaBioscience Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. AltaBioscience Custom Antibody Development and Production Service Product Portfolio Table 104. AltaBioscience Recent Development Table 105. Creative Biolabs Company Information Table 106. Creative Biolabs Business Overview Table 107. Creative Biolabs Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Creative Biolabs Custom Antibody Development and Production Service Product Portfolio Table 109. Creative Biolabs Recent Development Table 110. Rockland Company Information Table 111. Rockland Business Overview Table 112. Rockland Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Rockland Custom Antibody Development and Production Service Product Portfolio Table 114. Rockland Recent Development Table 115. Biosynth Company Information Table 116. Biosynth Business Overview Table 117. Biosynth Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Biosynth Custom Antibody Development and Production Service Product Portfolio Table 119. Biosynth Recent Development Table 120. ProSci Company Information Table 121. ProSci Business Overview Table 122. ProSci Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. ProSci Custom Antibody Development and Production Service Product Portfolio Table 124. ProSci Recent Development Table 125. Abclonal Company Information Table 126. Abclonal Business Overview Table 127. Abclonal Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Abclonal Custom Antibody Development and Production Service Product Portfolio Table 129. Abclonal Recent Development Table 130. Eurogentec Company Information Table 131. Eurogentec Business Overview Table 132. Eurogentec Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Eurogentec Custom Antibody Development and Production Service Product Portfolio Table 134. Eurogentec Recent Development Table 135. Creative Diagnostics Company Information Table 136. Creative Diagnostics Business Overview Table 137. Creative Diagnostics Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Creative Diagnostics Custom Antibody Development and Production Service Product Portfolio Table 139. Creative Diagnostics Recent Development Table 140. BioGenes Company Information Table 141. BioGenes Business Overview Table 142. BioGenes Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. BioGenes Custom Antibody Development and Production Service Product Portfolio Table 144. BioGenes Recent Development Table 145. Biomolecular Discovery Services, LLC. Company Information Table 146. Biomolecular Discovery Services, LLC. Business Overview Table 147. Biomolecular Discovery Services, LLC. Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Biomolecular Discovery Services, LLC. Custom Antibody Development and Production Service Product Portfolio Table 149. Biomolecular Discovery Services, LLC. Recent Development Table 150. Proteintech Group Company Information Table 151. Proteintech Group Business Overview Table 152. Proteintech Group Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. Proteintech Group Custom Antibody Development and Production Service Product Portfolio Table 154. Proteintech Group Recent Development Table 155. HUABIO Company Information Table 156. HUABIO Business Overview Table 157. HUABIO Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 158. HUABIO Custom Antibody Development and Production Service Product Portfolio Table 159. HUABIO Recent Development Table 160. MyBioSource Company Information Table 161. MyBioSource Business Overview Table 162. MyBioSource Custom Antibody Development and Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 163. MyBioSource Custom Antibody Development and Production Service Product Portfolio Table 164. MyBioSource Recent Development Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Custom Antibody Development and Production Service Product Image Figure 2. Global Custom Antibody Development and Production Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Antibody Development and Production Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Custom Antibody Development and Production Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Polyclonal Antibody Image Figure 8. Monoclonal Antibody Image Figure 9. Recombinant Antibody Image Figure 10. Global Custom Antibody Development and Production Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Custom Antibody Development and Production Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Custom Antibody Development and Production Service Sales Value Share by Type (2021-2032) Figure 13. Research Image Figure 14. Diagnosis Image Figure 15. Treatment and Clinical Practice Image Figure 16. Global Custom Antibody Development and Production Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Custom Antibody Development and Production Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Custom Antibody Development and Production Service Sales Value Share by Application (2021-2032) Figure 19. Global Custom Antibody Development and Production Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Custom Antibody Development and Production Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Custom Antibody Development and Production Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Custom Antibody Development and Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Custom Antibody Development and Production Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Custom Antibody Development and Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Custom Antibody Development and Production Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Custom Antibody Development and Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Custom Antibody Development and Production Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Custom Antibody Development and Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Custom Antibody Development and Production Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Custom Antibody Development and Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal Antibody
  • Monoclonal Antibody
  • Recombinant Antibody
Applications
  • Research
  • Diagnosis
  • Treatment and Clinical Practice
Companies covered
  • Thermo Fisher Scientific
  • Sino Biological
  • Inotiv
  • GenScript
  • R&D Systems
  • Proteogenix
  • BBI Solutions
  • Bio-Rad Laboratories
  • Bio-Techne
  • Abcam
  • OriGene
  • Innovagen
  • AltaBioscience
  • Creative Biolabs
  • Rockland
  • Biosynth
  • ProSci
  • Abclonal
  • Eurogentec
  • Creative Diagnostics
  • BioGenes
  • Biomolecular Discovery Services, LLC.
  • Proteintech Group
  • HUABIO
  • MyBioSource

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Custom Antibody Development and Production Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Custom Antibody Development and Production Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Custom Antibody Development and Production Service Market Dynamics
  1. 2.1 Custom Antibody Development and Production Service Industry Trends
  2. 2.2 Custom Antibody Development and Production Service Industry Drivers
  3. 2.3 Custom Antibody Development and Production Service Industry Opportunities and Challenges
  4. 2.4 Custom Antibody Development and Production Service Industry Restraints
3 Custom Antibody Development and Production Service Market by Company
  1. 3.1 Global Custom Antibody Development and Production Service Company Revenue Ranking in 2025
  2. 3.2 Global Custom Antibody Development and Production Service Revenue by Company (2021-2026)
  3. 3.3 Global Custom Antibody Development and Production Service Company Ranking (2024-2026)
  4. 3.4 Global Custom Antibody Development and Production Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Custom Antibody Development and Production Service Company Product Type and Application
  6. 3.6 Global Custom Antibody Development and Production Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Custom Antibody Development and Production Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Custom Antibody Development and Production Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Custom Antibody Development and Production Service Market by Type
  1. 4.1 Custom Antibody Development and Production Service Type Introduction
  2. 4.1.1 Polyclonal Antibody
  3. 4.1.2 Monoclonal Antibody
  4. 4.1.3 Recombinant Antibody
  5. 4.2 Global Custom Antibody Development and Production Service Sales Value by Type
  6. 4.2.1 Global Custom Antibody Development and Production Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Custom Antibody Development and Production Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Custom Antibody Development and Production Service Sales Value Share by Type (2021-2032)
5 Custom Antibody Development and Production Service Market by Application
  1. 5.1 Custom Antibody Development and Production Service Application Introduction
  2. 5.1.1 Research
  3. 5.1.2 Diagnosis
  4. 5.1.3 Treatment and Clinical Practice
  5. 5.2 Global Custom Antibody Development and Production Service Sales Value by Application
  6. 5.2.1 Global Custom Antibody Development and Production Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Custom Antibody Development and Production Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Custom Antibody Development and Production Service Sales Value Share by Application (2021-2032)
6 Custom Antibody Development and Production Service Regional Value Analysis
  1. 6.1 Global Custom Antibody Development and Production Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Custom Antibody Development and Production Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Custom Antibody Development and Production Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Custom Antibody Development and Production Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Custom Antibody Development and Production Service Sales Value (2021-2032)
  7. 6.3.2 North America Custom Antibody Development and Production Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Custom Antibody Development and Production Service Sales Value (2021-2032)
  10. 6.4.2 Europe Custom Antibody Development and Production Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Custom Antibody Development and Production Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Custom Antibody Development and Production Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Custom Antibody Development and Production Service Sales Value (2021-2032)
  16. 6.6.2 South America Custom Antibody Development and Production Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Custom Antibody Development and Production Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Custom Antibody Development and Production Service Sales Value Share by Country, 2025 VS 2032
7 Custom Antibody Development and Production Service Country-level Value Analysis
  1. 7.1 Global Custom Antibody Development and Production Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Custom Antibody Development and Production Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Custom Antibody Development and Production Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Custom Antibody Development and Production Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Custom Antibody Development and Production Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Custom Antibody Development and Production Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Custom Antibody Development and Production Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Custom Antibody Development and Production Service Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Sino Biological
  8. 8.2.1 Sino Biological Company Information
  9. 8.2.2 Sino Biological Business Overview
  10. 8.2.3 Sino Biological Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sino Biological Custom Antibody Development and Production Service Product Portfolio
  12. 8.2.5 Sino Biological Recent Developments
  13. 8.3 Inotiv
  14. 8.3.1 Inotiv Company Information
  15. 8.3.2 Inotiv Business Overview
  16. 8.3.3 Inotiv Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Inotiv Custom Antibody Development and Production Service Product Portfolio
  18. 8.3.5 Inotiv Recent Developments
  19. 8.4 GenScript
  20. 8.4.1 GenScript Company Information
  21. 8.4.2 GenScript Business Overview
  22. 8.4.3 GenScript Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GenScript Custom Antibody Development and Production Service Product Portfolio
  24. 8.4.5 GenScript Recent Developments
  25. 8.5 R&D Systems
  26. 8.5.1 R&D Systems Company Information
  27. 8.5.2 R&D Systems Business Overview
  28. 8.5.3 R&D Systems Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 R&D Systems Custom Antibody Development and Production Service Product Portfolio
  30. 8.5.5 R&D Systems Recent Developments
  31. 8.6 Proteogenix
  32. 8.6.1 Proteogenix Company Information
  33. 8.6.2 Proteogenix Business Overview
  34. 8.6.3 Proteogenix Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Proteogenix Custom Antibody Development and Production Service Product Portfolio
  36. 8.6.5 Proteogenix Recent Developments
  37. 8.7 BBI Solutions
  38. 8.7.1 BBI Solutions Company Information
  39. 8.7.2 BBI Solutions Business Overview
  40. 8.7.3 BBI Solutions Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BBI Solutions Custom Antibody Development and Production Service Product Portfolio
  42. 8.7.5 BBI Solutions Recent Developments
  43. 8.8 Bio-Rad Laboratories
  44. 8.8.1 Bio-Rad Laboratories Company Information
  45. 8.8.2 Bio-Rad Laboratories Business Overview
  46. 8.8.3 Bio-Rad Laboratories Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bio-Rad Laboratories Custom Antibody Development and Production Service Product Portfolio
  48. 8.8.5 Bio-Rad Laboratories Recent Developments
  49. 8.9 Bio-Techne
  50. 8.9.1 Bio-Techne Company Information
  51. 8.9.2 Bio-Techne Business Overview
  52. 8.9.3 Bio-Techne Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bio-Techne Custom Antibody Development and Production Service Product Portfolio
  54. 8.9.5 Bio-Techne Recent Developments
  55. 8.10 Abcam
  56. 8.10.1 Abcam Company Information
  57. 8.10.2 Abcam Business Overview
  58. 8.10.3 Abcam Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Abcam Custom Antibody Development and Production Service Product Portfolio
  60. 8.10.5 Abcam Recent Developments
  61. 8.11 OriGene
  62. 8.11.1 OriGene Company Information
  63. 8.11.2 OriGene Business Overview
  64. 8.11.3 OriGene Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 OriGene Custom Antibody Development and Production Service Product Portfolio
  66. 8.11.5 OriGene Recent Developments
  67. 8.12 Innovagen
  68. 8.12.1 Innovagen Company Information
  69. 8.12.2 Innovagen Business Overview
  70. 8.12.3 Innovagen Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Innovagen Custom Antibody Development and Production Service Product Portfolio
  72. 8.12.5 Innovagen Recent Developments
  73. 8.13 AltaBioscience
  74. 8.13.1 AltaBioscience Company Information
  75. 8.13.2 AltaBioscience Business Overview
  76. 8.13.3 AltaBioscience Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AltaBioscience Custom Antibody Development and Production Service Product Portfolio
  78. 8.13.5 AltaBioscience Recent Developments
  79. 8.14 Creative Biolabs
  80. 8.14.1 Creative Biolabs Company Information
  81. 8.14.2 Creative Biolabs Business Overview
  82. 8.14.3 Creative Biolabs Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Creative Biolabs Custom Antibody Development and Production Service Product Portfolio
  84. 8.14.5 Creative Biolabs Recent Developments
  85. 8.15 Rockland
  86. 8.15.1 Rockland Company Information
  87. 8.15.2 Rockland Business Overview
  88. 8.15.3 Rockland Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Rockland Custom Antibody Development and Production Service Product Portfolio
  90. 8.15.5 Rockland Recent Developments
  91. 8.16 Biosynth
  92. 8.16.1 Biosynth Company Information
  93. 8.16.2 Biosynth Business Overview
  94. 8.16.3 Biosynth Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Biosynth Custom Antibody Development and Production Service Product Portfolio
  96. 8.16.5 Biosynth Recent Developments
  97. 8.17 ProSci
  98. 8.17.1 ProSci Company Information
  99. 8.17.2 ProSci Business Overview
  100. 8.17.3 ProSci Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 ProSci Custom Antibody Development and Production Service Product Portfolio
  102. 8.17.5 ProSci Recent Developments
  103. 8.18 Abclonal
  104. 8.18.1 Abclonal Company Information
  105. 8.18.2 Abclonal Business Overview
  106. 8.18.3 Abclonal Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Abclonal Custom Antibody Development and Production Service Product Portfolio
  108. 8.18.5 Abclonal Recent Developments
  109. 8.19 Eurogentec
  110. 8.19.1 Eurogentec Company Information
  111. 8.19.2 Eurogentec Business Overview
  112. 8.19.3 Eurogentec Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Eurogentec Custom Antibody Development and Production Service Product Portfolio
  114. 8.19.5 Eurogentec Recent Developments
  115. 8.20 Creative Diagnostics
  116. 8.20.1 Creative Diagnostics Company Information
  117. 8.20.2 Creative Diagnostics Business Overview
  118. 8.20.3 Creative Diagnostics Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Creative Diagnostics Custom Antibody Development and Production Service Product Portfolio
  120. 8.20.5 Creative Diagnostics Recent Developments
  121. 8.21 BioGenes
  122. 8.21.1 BioGenes Company Information
  123. 8.21.2 BioGenes Business Overview
  124. 8.21.3 BioGenes Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 BioGenes Custom Antibody Development and Production Service Product Portfolio
  126. 8.21.5 BioGenes Recent Developments
  127. 8.22 Biomolecular Discovery Services, LLC.
  128. 8.22.1 Biomolecular Discovery Services, LLC. Company Information
  129. 8.22.2 Biomolecular Discovery Services, LLC. Business Overview
  130. 8.22.3 Biomolecular Discovery Services, LLC. Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Biomolecular Discovery Services, LLC. Custom Antibody Development and Production Service Product Portfolio
  132. 8.22.5 Biomolecular Discovery Services, LLC. Recent Developments
  133. 8.23 Proteintech Group
  134. 8.23.1 Proteintech Group Company Information
  135. 8.23.2 Proteintech Group Business Overview
  136. 8.23.3 Proteintech Group Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Proteintech Group Custom Antibody Development and Production Service Product Portfolio
  138. 8.23.5 Proteintech Group Recent Developments
  139. 8.24 HUABIO
  140. 8.24.1 HUABIO Company Information
  141. 8.24.2 HUABIO Business Overview
  142. 8.24.3 HUABIO Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  143. 8.24.4 HUABIO Custom Antibody Development and Production Service Product Portfolio
  144. 8.24.5 HUABIO Recent Developments
  145. 8.25 MyBioSource
  146. 8.25.1 MyBioSource Company Information
  147. 8.25.2 MyBioSource Business Overview
  148. 8.25.3 MyBioSource Custom Antibody Development and Production Service Revenue and Gross Margin (2021-2026)
  149. 8.25.4 MyBioSource Custom Antibody Development and Production Service Product Portfolio
  150. 8.25.5 MyBioSource Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst